Cargando…
Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening
OBJECTIVE: To find a hematological parameter and the cut-off level for identification of nonsickling hemoglobinopathies in pregnant women. MATERIALS AND METHODS: Venous blood samples of 849 women with singleton pregnancies were collected at the first visit. All women who met inclusion criteria were...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399595/ https://www.ncbi.nlm.nih.gov/pubmed/25914560 http://dx.doi.org/10.2147/IJWH.S73362 |
_version_ | 1782366951957331968 |
---|---|
author | Bencaiova, Gabriela Dapoto, Kristina Zimmermann, Roland Krafft, Alexander |
author_facet | Bencaiova, Gabriela Dapoto, Kristina Zimmermann, Roland Krafft, Alexander |
author_sort | Bencaiova, Gabriela |
collection | PubMed |
description | OBJECTIVE: To find a hematological parameter and the cut-off level for identification of nonsickling hemoglobinopathies in pregnant women. MATERIALS AND METHODS: Venous blood samples of 849 women with singleton pregnancies were collected at the first visit. All women who met inclusion criteria were examined for nonsickling hemoglobinopathy. On the basis of the sensitivity and the specificity of different cut-off levels for hematological parameters, we calculated the optimal clinically practicable parameter for screening of nonsickling hemoglobinopathies in pregnant women. RESULTS: On the basis of the sensitivity and the specificity, the best screening parameters for the identification of nonsickling hemoglobinopathies among nonanemic pregnant women are mean corpuscular volume (MCV) with cut-off ≤80 fL (Youden’s index 91.2%), mean corpuscular hemoglobin (MCH) <27.5 pg (Youden’s index 90.7%), and microcytosis (MRC) ≥3% (Youden’s index 90.2%). An analysis using receiver operating characteristic curves and the calculated Youden’s index showed that MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10% are the best red blood cell indices for the screening of nonsickling hemoglobinopathy among anemic women with iron deficiency. CONCLUSION: Our results suggest targeted screening for nonsickling hemoglobinopathies in nonanemic pregnant women with MCV ≤80 fL, MCH ≤27.5 pg, or MRC ≥3% and in anemic women with MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10%. |
format | Online Article Text |
id | pubmed-4399595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-43995952015-04-24 Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening Bencaiova, Gabriela Dapoto, Kristina Zimmermann, Roland Krafft, Alexander Int J Womens Health Original Research OBJECTIVE: To find a hematological parameter and the cut-off level for identification of nonsickling hemoglobinopathies in pregnant women. MATERIALS AND METHODS: Venous blood samples of 849 women with singleton pregnancies were collected at the first visit. All women who met inclusion criteria were examined for nonsickling hemoglobinopathy. On the basis of the sensitivity and the specificity of different cut-off levels for hematological parameters, we calculated the optimal clinically practicable parameter for screening of nonsickling hemoglobinopathies in pregnant women. RESULTS: On the basis of the sensitivity and the specificity, the best screening parameters for the identification of nonsickling hemoglobinopathies among nonanemic pregnant women are mean corpuscular volume (MCV) with cut-off ≤80 fL (Youden’s index 91.2%), mean corpuscular hemoglobin (MCH) <27.5 pg (Youden’s index 90.7%), and microcytosis (MRC) ≥3% (Youden’s index 90.2%). An analysis using receiver operating characteristic curves and the calculated Youden’s index showed that MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10% are the best red blood cell indices for the screening of nonsickling hemoglobinopathy among anemic women with iron deficiency. CONCLUSION: Our results suggest targeted screening for nonsickling hemoglobinopathies in nonanemic pregnant women with MCV ≤80 fL, MCH ≤27.5 pg, or MRC ≥3% and in anemic women with MCV ≤76 fL, MCH ≤24 pg, or MRC ≥10%. Dove Medical Press 2015-04-08 /pmc/articles/PMC4399595/ /pubmed/25914560 http://dx.doi.org/10.2147/IJWH.S73362 Text en © 2015 Bencaiova et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Bencaiova, Gabriela Dapoto, Kristina Zimmermann, Roland Krafft, Alexander Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title | Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title_full | Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title_fullStr | Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title_full_unstemmed | Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title_short | Red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
title_sort | red blood cell parameters in antenatal nonsickling hemoglobinopathy screening |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399595/ https://www.ncbi.nlm.nih.gov/pubmed/25914560 http://dx.doi.org/10.2147/IJWH.S73362 |
work_keys_str_mv | AT bencaiovagabriela redbloodcellparametersinantenatalnonsicklinghemoglobinopathyscreening AT dapotokristina redbloodcellparametersinantenatalnonsicklinghemoglobinopathyscreening AT zimmermannroland redbloodcellparametersinantenatalnonsicklinghemoglobinopathyscreening AT krafftalexander redbloodcellparametersinantenatalnonsicklinghemoglobinopathyscreening |